Deus/GEMS
This article was originally published in The Gray Sheet
Executive Summary
Deus Technologies will develop a new digital lung cancer detection system for use with GE Medical Systems' suite of digital radiography x-ray systems. Deus currently markets the RapidScreen RS-2000, the only FDA-approved device for early lung cancer detection, for use with analog x-ray (1"The Gray Sheet" July 30, 2001, p. 15). According to the terms of the deal, GE will have exclusive distribution rights to the new digital product...